Gaudium IVF

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE0P8B01020
  • NSEID: GAUDIUMIVF
  • BSEID: 544709
INR
73.36
-1.9 (-2.52%)
BSENSE

Mar 30

BSE+NSE Vol: 4.64 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

4.64 lacs (-21.97%) Volume

Shareholding (Feb 2026)

FII

9.24%

Held by 8 FIIs

DII

5.05%

Held by 2 DIIs

Promoter

71.29%

Why is Gaudium IVF and Women Health Ltd falling/rising?

31-Mar-2026

As of 30-Mar, Gaudium IVF and Women Health Ltd's stock price is declining, currently at Rs 73.36, reflecting a 2.52% decrease. The stock has underperformed significantly, with a 10.09% decline over the past month and reduced investor interest indicated by a 73.05% drop in delivery volume.

As of 30-Mar, Gaudium IVF and Women Health Ltd's stock price is falling, currently at Rs 73.36, which reflects a decrease of Rs 1.9 or 2.52%. The stock has been underperforming, having lost 6.67% over the last two days and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the stock touched an intraday low of Rs 71, indicating significant downward pressure. <BR><BR>Investor participation has also declined, with delivery volume dropping by 73.05% compared to the 5-day average, suggesting reduced interest from investors. Furthermore, the stock has underperformed its sector by 0.64% today, contributing to the overall negative sentiment surrounding it. Despite a positive performance over the past week compared to the Sensex, the longer-term trends show a decline of 10.09% over the past month, which aligns with the broader market's struggles.

View full answer

Which are the latest news on Gaudium IVF?

31-Mar-2026
No latest news for Gaudium IVF found.

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 549 Cr (Micro Cap)

stock-summary
P/E

29.00

stock-summary
Industry P/E

55

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.27

stock-summary
Return on Equity

36.63%

stock-summary
Price to Book

12.09

Revenue and Profits:
Net Sales:
25 Cr
(Quarterly Results - Dec 2025)
Net Profit:
4 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Closure of Trading Window

28-Mar-2026 | Source : BSE

Pursuant to the provisions of the Code on Prohibition of Insider Trading of Gaudium IVF and Women Health Limited (Company) and the SEBI PIT Regulations 2015 as amended from time to time we wish to inform you that the trading window for trading in shares of the Company will remain closed for all designated persons and their immediate relative(s) from Wednesday April 01 2026 till 48 hours after the declaration of financial results of the Company for the quarter and year ended March 31 2026

Announcement under Regulation 30 (LODR)-Newspaper Publication

19-Mar-2026 | Source : BSE

Pursuant to Regulation 47 of SEBI Listing Regulations 2015 copies of newspaper publication of Unaudited Financial Results for the quater & nine months ended December 31 2025 is attached herewith.

Announcement under Regulation 30 (LODR)-Press Release / Media Release

19-Mar-2026 | Source : BSE

Press Release on the Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
19.98
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
24.53%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
14.35%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
29
Industry P/E
55
Price to Book Value
11.75
EV to EBIT
21.13
EV to EBITDA
19.60
EV to Capital Employed
9.48
EV to Sales
9.26
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
44.85%
ROE (Latest)
41.01%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
Bollinger Bands
KST
Dow Theory
OBV
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Feb 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 8 FIIs (9.24%)

Promoter with highest holding

Manika Khanna (70.73%)

Highest Public shareholder

Meru Investment Fund Pcc-cell 1 (2.96%)

Individual Investors Holdings

13.52%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -38.17% vs 64.52% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -64.78% vs 169.55% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14.19",
          "val2": "22.95",
          "chgp": "-38.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.83",
          "val2": "13.28",
          "chgp": "-56.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.12",
          "val2": "0.51",
          "chgp": "119.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "3.18",
          "val2": "9.03",
          "chgp": "-64.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "41.09%",
          "val2": "57.86%",
          "chgp": "-16.77%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Gaudium IVF"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Gaudium IVF"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 12.98% vs 18.65% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 11.96% vs 25.49% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "59.00",
          "val2": "52.22",
          "chgp": "12.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "27.86",
          "val2": "25.07",
          "chgp": "11.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.39",
          "val2": "0.54",
          "chgp": "157.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "18.63",
          "val2": "16.64",
          "chgp": "11.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "47.22%",
          "val2": "48.01%",
          "chgp": "-0.79%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
14.19
22.95
-38.17%
Operating Profit (PBDIT) excl Other Income
5.83
13.28
-56.10%
Interest
1.12
0.51
119.61%
Exceptional Items
0.00
0.00
Standalone Net Profit
3.18
9.03
-64.78%
Operating Profit Margin (Excl OI)
41.09%
57.86%
-16.77%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is -38.17% vs 64.52% in Sep 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -64.78% vs 169.55% in Sep 2025

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
59.00
52.22
12.98%
Operating Profit (PBDIT) excl Other Income
27.86
25.07
11.13%
Interest
1.39
0.54
157.41%
Exceptional Items
0.00
0.00
Standalone Net Profit
18.63
16.64
11.96%
Operating Profit Margin (Excl OI)
47.22%
48.01%
-0.79%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 12.98% vs 18.65% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is 11.96% vs 25.49% in Mar 2024

stock-summaryCompany CV
About Gaudium IVF and Women Health Ltd stock-summary
stock-summary
Gaudium IVF and Women Health Ltd
Micro Cap
Healthcare Services
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available